Source: Eur Respir J, 56 (1) 2001190; 10.1183/13993003.01190-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Yu Fu, Ping Han, Rui Zhu, Tao Bai, Jianhua Yi, Xi Zhao, Meihui Tao, Runze Quan, Chaoyue Chen, Ying Zhang, Qin He, Mengjia Jing, Xiaofeng Xiong, Dean Tian, Wei Yan. Risk factors for viral RNA shedding in COVID-19 patients. Eur Respir J, 56 (1) 2001190; 10.1183/13993003.01190-2020

Member's Comments

No comment yet.

Related content which might interest you: Prolonged viral RNA shedding in patients with COVID-19 infection Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Impact of viral load on mortality in hospitalized patients affected by Covid-19 infection. Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Risk factors associated with dinapenia in subjects recovered from COVID-19 Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021 Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome Source: Eur Respir J 2001; 17: 636-640 Year: 2001 Incidence and risk factors for structural lung disease following SARS-CoV-2 infection Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Risk factors for bacterial infection in exacerbated COPD requiring admission Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001 Enhanced severity of virus associated asthma exacerbations is not associated with delayed viral clearance and increased viral load Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005 Prevention and treatment of viral infections: CMV and other community respiratory viruses Source: ERS Course 2016 Year: 2016 The risk factors in asthma patients for COVID19 infection Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Pathomechanisms mediating bacterial co-infection following respiratory viral disease Source: Lung Science Conference 2015 Year: 2015 Risk factors of drug -induced hepatitis among patients with TB/HIV co-infection Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Comparison of risk factors for childhood pneumonia with RSV versus other viruses Source: International Congress 2016 – Paediatric respiratory infections Year: 2016 COPD and respiratory viral infections as risk factors for the development of cardiovascular events Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Risk factors associated with hospitalized asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 Risk factors for long-term hospitalization in patients with COVID 19 Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Host and viral factors predicting severity of rhinovirus-associated wheeze Source: Annual Congress 2012 - New insights into respiratory infections in children Year: 2012 Viral infection Source: Eur Respir Monogr 2017; 77: 76-96 Year: 2017 Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children? Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008 COPD as an additional risk factor for cardiovascular and respiratory events in patients with respiratory viral infection Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019